Short Interest in PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Expands By 109.6%

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) saw a significant growth in short interest in the month of June. As of June 15th, there was short interest totaling 17,420 shares, a growth of 109.6% from the May 31st total of 8,311 shares. Based on an average daily volume of 260,335 shares, the short-interest ratio is presently 0.1 days.

PharmaTher Price Performance

OTCMKTS PHRRF opened at $0.04 on Thursday. The firm has a 50 day simple moving average of $0.05 and a 200-day simple moving average of $0.06. PharmaTher has a one year low of $0.03 and a one year high of $0.55.

PharmaTher Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.